Amryt Pharma (LON:AMYT) Stock Price Passes Below 50 Day Moving Average of $143.00

Amryt Pharma plc (LON:AMYTGet Free Report) crossed below its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of GBX 143 ($1.81) and traded as low as GBX 143 ($1.81). Amryt Pharma shares last traded at GBX 143 ($1.81), with a volume of 90,726 shares.

Amryt Pharma Trading Down 11.7 %

The stock has a market cap of £457.11 million and a PE ratio of -4.33. The company’s 50-day moving average price is GBX 143 and its 200 day moving average price is GBX 143. The company has a debt-to-equity ratio of 66.05, a quick ratio of 1.14 and a current ratio of 1.80.

About Amryt Pharma

(Get Free Report)

Amryt Pharma plc, a commercial-stage biopharmaceutical company, develops and commercializes novel therapeutics to treat patients suffering from serious and life-threatening rare diseases. The company offers Lomitapide for the treatment of homozygous familial hypercholesterolemia; and Metreleptin for the treatment of generalized and partial lipodystrophy.

Featured Articles

Receive News & Ratings for Amryt Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amryt Pharma and related companies with MarketBeat.com's FREE daily email newsletter.